SvatiShah Profile Banner
Svati Shah Profile
Svati Shah

@SvatiShah

Followers
3K
Following
9K
Media
126
Statuses
2K

Cardiologist studying genetics and metabolism

Durham, NC
Joined October 2017
Don't wanna be here? Send us removal request.
@SvatiShah
Svati Shah
10 months
Congratulations @DrPRao! So well deserved!!
@DrPRao
Dr. Prashant Rao
10 months
Huge s/o to the Gerszten lab (peer mentorship was invaluable!) and scientific advisory committee: @JenHoCardiology @SvatiShah @longlabstanford Dr. Benjamin Levine Excited to share more insights as this project develops!
1
0
3
@JCardFail
Journal of Cardiac Failure
10 months
Should there be systematic genetic screening for the most common variants of TTR amyloidosis? This piece explores the gaps & considerations of implementing V142I variant screening programs🧬 🔗 https://t.co/XlUqWYuB3w
3
12
20
@AndrewJSauer
Andrew J Sauer MD
10 months
📰A professional update 🔥 My recent boss, mentor, and friend @MkosiborodMD recently left @MidAmericaHeart and @saintlukeskc to lead late-stage CVRM development for @AstraZeneca. As a result, I am assuming a number of vacated leadership roles, including: Executive Director,
10
9
72
@AHAScience
AHA Science
11 months
CPET is essential for comprehensive care of patients w/ CHD, offering valuable prognostic insights & assisting in clinical decision-making across various congenital heart conditions, thereby significantly ⬆️patient management & outcomes. ✍🏼 @AdamPowellMD @_Dave_W @BarbaraCifra
2
9
42
@FudimMarat
Marat Fudim, MD MHS
11 months
1/ 🌟 New treatment paradigm in heart failure! The REMOTE-HF study explored BAY 2413555, a novel M2 receptor modulator aiming to enhance parasympathetic activity in HF patients. Findings show promise but come with some caveats https://t.co/nsikwdfGZn
5
16
61
@SvatiShah
Svati Shah
11 months
Fantastic talk from super ⭐️ @jregan2012 at @DukeMedSchool Precision Genomics Collaboratory retreat, 2nd place for best oral presentation! Metabolic pathways and snRNAseq for epicardial and pericoronary fat
0
1
27
@SvatiShah
Svati Shah
11 months
Awesome talk from the incredible @drmrscoles at @DukeMedSchool genomics symposium. Cool work w/ a homegrown pipeline for WGS to identify causative genetic variants in families with arrhythmias. Sara is a rising ⭐️ in EP and arrhythmia genetics 🧬, keep an 👁️ out for her!
2
2
29
@MariosGeorgakis
Marios Georgakis
1 year
This @CellCellPress paper making the most of the #proteomics resource of the UK Biobank is a great Sunday read📖❗️ 🔗 https://t.co/P0Sh5ssdnH It highlights at scale the areas, where proteomics could provide meaningful insights: 🧵
1
48
196
@pnatarajanmd
Pradeep Natarajan
1 year
Free nationwide genetic carrier screening of 10K reproductive couples during current or planned pregnancy offered during carrier screening for 1300 genes in Australia reported. 1 in 50 with a positive result & influenced pregnancy plans https://t.co/mpRPYbgy6A @NEJM
1
4
25
@DukeGenomics
DukePrecisionGenomics
1 year
Our 4th annual Genomics Scientific Retreat is only 3 weeks away! https://t.co/AbxpTjpDTX
0
3
3
@CircHF
Circ: Heart Failure
1 year
SGLT2i demonstrate common (fatty acid) and distinct (ketogenic) metabolic signatures across the LVEF spectrum @senthil_selv @SvatiShah @MkosiborodMD @DukeHeartCenter @MidAmericaHeart @HFpEF @bborlaugmd https://t.co/NoRgmlwpKS
0
4
11
@SvatiShah
Svati Shah
1 year
Congratulations, great work @senthil_selv! A great step towards use of exogenous ketone therapy in HF
@senthil_selv
Senthil Selvaraj, MD, MS, MA
1 year
Our phase I study of 2 doses of exogenous ketones detailing PK and metabolic profiling in HFrEF by background SGLT2i Simpub #AHA24 & @JACCJournals #JACCBTS https://t.co/iIR6V17X3i 🙏 @SvatiShah @MarguliesLab @robmentz @FudimMarat and outstanding team @DukeHeartCenter @DukeMPI
1
1
26
@DrSafarova
Maya S Safarova, MD, PhD
1 year
#AHA24 Genomics and Precision Medicine Council @American_Heart on training in #CardioGenomics Thrilled to see major efforts in this direction @APLandstrom @AnwarChahal @rodendm @SvatiShah @iftikhar_kullo @MJAckermanMDPhD
Tweet card summary image
ahajournals.org
@DrSafarova
Maya S Safarova, MD, PhD
4 years
Thank you @NatRevCardiol for sharing our vision for the future of #AHAFIT #ACCFIT training in #CardioGenomics recognizing the growing need for a #Cardiovascular #Genomics subspecialty  #PrecisionMedicine @NLAWIL @WomenAs1 @CardioNerds @CardioSmart @KUCVM https://t.co/WykmnV39uY
1
2
10
@David_Ouyang
David Ouyang, MD
1 year
Excited to be at #AHA24 and share the excellent work of our trainees, collaborators, and friends!
1
14
60
@FudimMarat
Marat Fudim, MD MHS
1 year
#AHA24 Early Career Spotlight on some amazing young and promising talent in the space of CV medicine. From Software to Hemodynamics, everything was represented. Thanks for AHA for funding this work. The future is bright. @AHAScience @AHAMeetings @emilyswlau @JessicaBlairB
1
5
46
@dramitkhera
Amit Khera
1 year
Key programming for women in cardiology at #AHA24 Thanks to the developers and participants of these excellent sessions. @MonSangh @DrMarthaGulati @ErinMichos @Drroxmehran @JoChikweMD @SvatiShah @AHAScience @AnastasiaSMihai
@MonSangh
Monika Sanghavi MD, FACC
1 year
Making you schedule for #AHA2024? Check out some of the professional development programming below!
1
15
48
@mad_sters
Madeline Sterling, MD, MPH, FAHA
1 year
NEW @AHAScience Scientific Statement from the Inaugural Primary Care Science Committee !! "Role of Primary Care in Achieving Life's Essential 8" @CircOutcomes Key takeaways ✅here: https://t.co/cFbqDfhKyx Article 📰 here: https://t.co/4vZzxX0RNz
4
23
83
@RajgopalRadhika
Radhika Rajgopal Singh
1 year
New science advisory on Gene Therapy in CVD👇👇thanks to @P_StLaurent @yurikim_mdphd @APLandstrom @SvatiShah @Joseph_C_Wu and the fantastic Kricket Seidman
@AHAScience
AHA Science
1 year
🆕AHA advisory published on Gene Therapy in Cardiovascular Disease. Education on genetic concepts, test results, & therapies to benefit patients & reduce the burden of CVD is critical. 📷 Delivery methods for gene therapy ✍🏼 @yurikim_mdphd @APLandstrom @SvatiShah @Joseph_C_Wu
0
3
9
@yurikim_mdphd
Yuri Kim
1 year
Very excited to share our AHA Science Advisory where we discuss current promises and limitations of gene therapy in CVD. It was such an honor to work with @APLandstrom @SvatiShah @Joseph_C_Wu, Kricket, @AHAScience @American_Heart and @CircAHA @bwhcvls @BrighamWomens #GeneTherapy
@AHAScience
AHA Science
1 year
CVD is the leading cause of 🌏 morbidity & mortality. Many are caused by damaging DNA 🧬 variants and require lifelong treatments that mitigate but do not cure disease. This advisory looks at gene therapies to treat CVD. ✍🏼: @yurikim_mdphd @APLandstrom @SvatiShah @Joseph_C_Wu
5
9
65
@AHAScience
AHA Science
1 year
CVD is the leading cause of 🌏 morbidity & mortality. Many are caused by damaging DNA 🧬 variants and require lifelong treatments that mitigate but do not cure disease. This advisory looks at gene therapies to treat CVD. ✍🏼: @yurikim_mdphd @APLandstrom @SvatiShah @Joseph_C_Wu
4
24
67